Cargando…
Retinal haemangioblastomas in von Hippel–Lindau germline mutation carriers: progression, complications and treatment outcome
PURPOSE: Evaluation of phenotype and treatment outcome of retinal haemangioblastomas (RH) in von Hippel–Lindau (VHL) disease and correlation of these features with the genotype of VHL germline mutation carriers. METHODS: Retrospective analysis of a longitudinal cohort of 21 VHL germline mutation car...
Autores principales: | Hajjaj, Anass, van Overdam, Koen A., Oldenburg, Rogier A., Koopmans, Anna E., van den Ouweland, Ans M. W., de Klein, Annelies, Kiliç, Emine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496349/ https://www.ncbi.nlm.nih.gov/pubmed/32003155 http://dx.doi.org/10.1111/aos.14360 |
Ejemplares similares
-
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Supratentorial dural-based haemangioblastoma in a Native American patient without Von Hippel Lindau Syndrome
por: Kaloostian, PE, et al.
Publicado: (2012) -
Supratentorial haemangioblastoma without von Hippel–Lindau syndrome in an adult: A rare tumor with review of literature
por: Pandey, Sharad, et al.
Publicado: (2016) -
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel–Lindau Disease
por: Furness, Hugh, et al.
Publicado: (2021) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005)